Cubist Systematic Strategies »

4d Molecular Therapeutics In shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2024-09-30 $222k 21k 10.81
2023-06-30 $18 1 18.00
2023-03-31 $31k 1.8k 17.19
2022-12-31 $358k 16k 22.21
2022-06-30 $165k 24k 7.00
2021-12-31 $393k 18k 21.94

More positions owned by Cubist Systematic Strategies

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
Microsoft Corporation (MSFT)
Super Micro Computer Call Option (SMCI)
General Motors Company (GM)
Spotify Technology S A SHS (SPOT)
Meta Platforms Cl A (META)
Micron Technology Call Option (MU)
Arm Holdings Sponsored Ads Call Option (ARM)
Intel Corporation Call Option (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Snowflake Cl A (SNOW)
Tesla Motors Call Option (TSLA)

View all positions for Cubist Systematic Strategies

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
BlackRock
BlackRock
VR Adviser
Goldman Sachs Group
Deep Track Capital
Henderson Group
Vanguard Group
State Street Corporation
Assenagon Asset Management
Novo A/S
Morgan Stanley
Redmile Group
Braidwell

View all funds holding 4d Molecular Therapeutics In